Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Cervical Cancer
- Immunotherapy
- Neoadjuvant Therapy
- Hormone Therapy
- General Oncology
- Radiological Techniques and Scans
- Sarcomas
- Brain and Spinal Cord Cancer
Welcome
Clinics in Oncology™ (Impact Factor: 2.709*) and (ISSN 2474-1663) is an interdisciplinary and borderless journal serves as the most reputable and authoritative platform for distributing key clinical oncology research to its readers, associated with Breast Cancer, Gastrointestinal Cancer, Hematologic Malignancies, Molecular Oncology, Thoracic Cancer, Genitourinary Cancer, Head and neck Cancer, Cervical Cancer, Bladder Cancer, Colon Cancer, Colorectal Cancer, Lung Cancer, Pediatric Cancer, Ovarian Cancer, Prostate Cancer, Surgical Oncology, Pediatric Oncology, Neuro-Oncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readers include active clinical oncologists in practice, researchers, students, trainees, and allied health professionals worldwide.
Clinics in Oncology™ (Impact Factor: 2.709*) encircles a wide range of informative and advanced articles that contribute significantly to the field of oncology. The journal's scope covers various aspects of oncology research, including basic science, translational research, clinical studies, and reviews.
NLM ID
Recently Published Articles
Surgical Safety and Efficacy of Self-Expandable Metal Stents in Left and Right-Side Malignant Obstruction Colon
Wang PC and Ye K
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2058. DOI: 10.25107/2474-1663.2058
Arachidonic Acid Induces Apoptosis Under Serum- Free Conditions by Blocking PAK1-Mediated PUMA Suppression
Ko S, Woo TG, Lee SH, Ha NC and Park BJ
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2053. DOI: 10.25107/2474-1663.2053
Isorhamnetin Inhibits the Proliferation and Induces Apoptosis of Hepatocellular Carcinoma by Targeting the GSK3-β/PI3K/AKT Pathway
Liu S, Lin Y, Li H, He X, Zhang C, Lan S, Yao X, Guo W and Chen H
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2052. DOI: 10.25107/2474-1663.2052
Targeted Therapy Directed Genes’ Genomic Profiling in Circulating Tumor DNA of Lung Cancer Patients
Baia L, Songa J, Zhaia J, Lia J, Lua X, Zhoua Y and Zhoua J
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2051. DOI: 10.25107/2474-1663.2051
The Clinical Picture of Patients with the Ultra-Extremely Low and Extremely High Total Level of Serum IgE in the Material of the Provincial Hospital in Opole from 2013- 2023
Warmuzińska A and Tubek S
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2050. DOI: 10.25107/2474-1663.2050
LUZP2 Inhibition Sensitizes Prostate Cancer to Chemotherapy by Suppressing RAD50
Xin L, Na-Er S, Jing-Lan H, Ping G and Xiao-Ming D
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2049. DOI: 10.25107/2474-1663.2049